(PRWEB) October 23, 2014
Capsugel scientists will talk about a range of advancements – like bioavailability enhancement and multi-particulate technologies, dry powder inhalation (DPI) technologies, and alternate-polymer and other specialized capsule technologies – at the 2014 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, which runs November 2-six in San Diego, Calif. The business will also showcase specialized gear to help crucial technologies in encapsulation and bioreactor method handle.

“It is an exciting time to be a scientist at Capsugel. Our advanced science and engineering, expanded technologies offerings, and the increasing synergies in between our Hard Capsule and Dosage Form Options (DFS) company units are top to new possibilities to develop value for our clients,” stated Keith Hutchison, Ph.D., Senior Vice President, Analysis & Improvement, Capsugel. “At AAPS, we look forward to discussing our approach to addressing customers’ most-pressing formulation challenges, including low and variable drug absorption, high-potency/low-dose specifications and modified drug release profiles and to demonstrating our distinctive ability to style, create and manufacture both state-of-the-art capsules and completed dosage forms.”

Firm scientists will present 20 technical posters and host a series of seminars on important innovations. Highlights consist of: 

New lipid multi-particulate (LMP) technologies, primarily based on Capsugel’s proprietary melt-spray congeal processing, supplying the functionality of lipid-based formulations with the patient and consumer rewards related with a multi-particulate drug delivery
Coni-Snap® sprinkle capsules developed for populations with swallowing difficulties, providing reproducible ease of opening for sufferers and caregivers
Integrated formulation and specialized capsule providing for Inhalation items, like particle engineering for optimized formulations and specialized DPI capsules for pulmonary delivery
Advancements in spray-dried dispersion and other bioavailability-enhancement technologies, pioneered by Bend Investigation, now a division of Capsugel Dosage Form Solutions.
Specialized equipment that will be featured at the booth involves Capsugel’s new Modular Automated Sampling Technology™ platform, or MAST, and its Xcelodose® precision powder micro-dosing technique. MAST is an automated, aseptic bioreactor sampling method that will aid advance the bioprocess sector toward actual-time testing, predictive control and general bioprocess guidance. Capsugel’s Xcelodose® system shortens drug improvement time, speeds 1st-in-human trials and lowers charges by minimizing the want for formulation and stability research just before API proof of notion is established.

Pay a visit to Capsugel’s booth #1422 to learn about innovative dosage technology and manufacturing options for the pharmaceutical business. An overview of poster presentations and seminars can be identified right here. Schedule a meeting with Capsugel in advance right here, and follow updates about the meeting at http://www.capsugel.com.

ABOUT CAPSUGEL
Capsugel is a international leader in delivering high-quality, revolutionary dosage types and solutions to its clients in the overall health care industry. The company’s Difficult Capsule organization offers clients the broadest portfolio of gelatin, vegetarian, and other specialized capsule technologies. Capsugel’s Dosage Form Solutions (DFS) organization utilizes an array of proprietary technologies and specialized manufacturing capabilities to resolve customers’ most pressing item improvement challenges, which includes bioavailability enhancement, modified release, abuse deterrence, biotherapeutic processing, and inhalation formulation. The company’s fast-to-clinic program streamlines solution development from pre-formulation via clinical and commercial provide for completed dosage types. Headquartered in Morristown, N.J., Capsugel serves a lot more than 4,000 clients in a lot more than one hundred nations. For extra information, go to http://www.capsugel.com.

For media inquiries, please make contact with Christina Chnaider at Christina(dot)Chnaider(at)capsugel(dot)com.





